Human Genome Epidemiology Literature Finder
Records 1 - 26 (of 26 Records) |
Query Trace: DCK[original query] |
---|
Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients. Pharmacogenetics 2004 Nov 14 (11): 759-68. Shi Jing-Yi, Shi Zhan-Zhong, Zhang Su-Jiang, Zhu Yong-Mei, Gu Bai-Wei, Li Guo, Bai Xue-Tao, Gao Xiao-Dong, Hu Jiong, Jin Wei, Huang Wei, Chen Zhu, Chen Sai-Ju |
Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteers. European journal of clinical pharmacology 2006 Aug 62 (8): 681-4. Joerger M, Bosch T M, Doodeman V D, Beijnen J H, Smits P H M, Schellens J H |
An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients. The oncologist 2007 Jun 12 (6): 622-30. Rha Sun Young, Jeung Hei Cheul, Choi Yeon Ho, Yang Woo Ick, Yoo Jin Ho, Kim Byung Soo, Roh Jae Kyung, Chung Hyun Che |
Twenty novel genetic variations and haplotype structures of the DCK gene encoding human deoxycytidine kinase (dCK). Drug metabolism and pharmacokinetics 2008 23 (5): 379-84. Kim Su-Ryang, Saito Yoshiro, Maekawa Keiko, Sugiyama Emiko, Kaniwa Nahoko, Ueno Hideki, Okusaka Takuji, Ikeda Masafumi, Morizane Chigusa, Yamamoto Noboru, Yoshida Teruhiko, Kamatani Naoyuki, Furuse Junji, Ishii Hiroshi, Saijo Nagahiro, Ozawa Shogo, Sawada Jun-Ic |
Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity. Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Jan 16 (1): 320-9. Okazaki Taro, Javle Milind, Tanaka Motofumi, Abbruzzese James L, Li Dongh |
Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms. Clinical pharmacokinetics 2010 Aug 49 (8): 549-58. Sugiyama Emiko, Kaniwa Nahoko, Kim Su-Ryang, Hasegawa Ryuichi, Saito Yoshiro, Ueno Hideki, Okusaka Takuji, Ikeda Masafumi, Morizane Chigusa, Kondo Shunsuke, Yamamoto Noboru, Tamura Tomohide, Furuse Junji, Ishii Hiroshi, Yoshida Teruhiko, Saijo Nagahiro, Sawada Jun-Ic |
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer. Cancer 2010 Nov 116 (22): 5325-35. Tanaka Motofumi, Javle Milind, Dong Xiaoqun, Eng Cathy, Abbruzzese James L, Li Dongh |
DNMT3A mutations in acute myeloid leukemia. The New England journal of medicine 2010 Dec 363 (25): 2424-33. Ley Timothy J, Ding Li, Walter Matthew J, McLellan Michael D, Lamprecht Tamara, Larson David E, Kandoth Cyriac, Payton Jacqueline E, Baty Jack, Welch John, Harris Christopher C, Lichti Cheryl F, Townsend R Reid, Fulton Robert S, Dooling David J, Koboldt Daniel C, Schmidt Heather, Zhang Qunyuan, Osborne John R, Lin Ling, O'Laughlin Michelle, McMichael Joshua F, Delehaunty Kim D, McGrath Sean D, Fulton Lucinda A, Magrini Vincent J, Vickery Tammi L, Hundal Jasreet, Cook Lisa L, Conyers Joshua J, Swift Gary W, Reed Jerry P, Alldredge Patricia A, Wylie Todd, Walker Jason, Kalicki Joelle, Watson Mark A, Heath Sharon, Shannon William D, Varghese Nobish, Nagarajan Rakesh, Westervelt Peter, Tomasson Michael H, Link Daniel C, Graubert Timothy A, DiPersio John F, Mardis Elaine R, Wilson Richard |
Effect of genetic alterations of cytarabine- metabolizing enzymes in childhood acute lymphoblastic leukemia. Hematology/oncology and stem cell therapy 2010 3 (3): 103-8. Banklau Chumphorn, Jindadamrongwech Sumalee, Sawangpanich Ruchchadol, Apibal Suntaree, Hongeng Suradej, Paisooksantivatana Karan, Pakakasama Sama |
Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma. Leukemia research 2011 Apr 35 (4): 431-7. Rivero Ana, Rapado Inmaculada, Tomás José F, Montalbán Carlos, de Oña Raquel, Paz-Carreira José, Canales Miguel, Martínez Rafael, Sánchez-Godoy Pedro, de Sevilla Alberto Fernández, de la Serna Javier, Martínez-López Joaqu |
The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C. Asia-Pacific journal of clinical oncology 2011 Mar 7 (1): 65-74. Metharom Ekkaphon, Galettis Peter, Manners Susan, Jelinek Maria, Liauw Winston, de Souza Paul L, Hoskins Janelle M, Links Matth |
Combined interaction of multi-locus genetic polymorphisms in cytarabine arabinoside metabolic pathway on clinical outcomes in adult acute myeloid leukaemia (AML) patients. European journal of cancer (Oxford, England : 1990) 2013 Jan 49 (2): 403-10. Kim Kyung Im, Huh Ik-Soo, Kim In-Wha, Park Taesung, Ahn Kwang-Sung, Yoon Sung-Soo, Yoon Jeong-Hyun, Oh Jung |
Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia. Chinese medical journal 2012 Jun 125 (12): 2137-43. Xu Pei-Pei, Chen Bao-An, Feng Ji-Feng, Cheng Lu, Xia Guo-Hua, Li Yu-Feng, Qian Jun, Ding Jia-Hua, Lu Zu-Hong, Wang Xue-Mei, Xu Ke, Schultz Margar |
Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors. Pharmacogenomics 2012 Jul 13 (9): 9. Mitra AK, Kirstein MN, Khatri A, Skubitz KM, Dudek AZ, Greeno EW, Kratzke RA, Lamba JK |
Lack of association of genetic variations of deoxycytidine kinase with toxicity or survival of non-small-cell lung cancer patients treated with gemcitabine plus cisplatin. Oncology research 2012 20 (1): 1. Ryu JS, Kim HJ, Shin ES, Nam HS, Cho JH, Lee JE |
Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5'-nucleotidase. American journal of hematology 2013 Dec 88 (12): 1001-6. Falk Ingrid Jakobsen, Fyrberg Anna, Paul Esbjörn, Nahi Hareth, Hermanson Monica, Rosenquist Richard, Höglund Martin, Palmqvist Lars, Stockelberg Dick, Wei Yuan, Gréen Henrik, Lotfi Kouro |
SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study. Journal of experimental & clinical cancer research : CR 2014 33 90. Wan Haixia, Zhu Jianyi, Chen Fangyuan, Xiao Fei, Huang Honghui, Han Xiaofeng, Zhong Lu, Zhong Hua, Xu Lan, Ni Beiwen, Zhong Jih |
The clinical implication of single nucleotide polymorphisms in deoxycytidine kinase in chronic hepatitis B patients treated with lamivudine. Journal of medical virology 2015 Sep . Lee Hyun Woong, Lee Sung Hee, Lee Min Goo, Ahn Sang Hoon, Chang Hye Young, Han Kwang-Hy |
Role of Genetic Polymorphisms of Deoxycytidine Kinase and Cytidine Deaminase to Predict Risk of Death in Children with Acute Myeloid Leukemia. BioMed research international 2015 2015 309491. Medina-Sanson Aurora, Ramírez-Pacheco Arturo, Moreno-Guerrero Silvia Selene, Dorantes-Acosta Elisa María, Sánchez-Preza Metzeri, Reyes-López Alfon |
Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia. Pediatric blood & cancer 2015 Apr 62 (4): 622-8. Gabor Krisztina Mita, Schermann Geza, Lautner-Csorba Orsolya, Rarosi Ferenc, Erdelyi Daniel J, Endreffy Emoke, Berek Krisztina, Bartyik Katalin, Bereczki Csaba, Szalai Csaba, Semsei Agnes |
Association between DCK 35708 T>C variation and clinical outcomes of acute myeloid leukemia in South Chinese patients. Pharmacogenomics 2016 Aug . Zhang Dao-Yu, Yuan Xiao-Qing, Yan Han, Cao Shan, Zhang Wei, Li Xiao-Lin, Zeng Hui, Chen Xiao-Pi |
dCK Expression and Gene Polymorphism With Gemcitabine Chemosensitivity in Patients With Pancreatic Ductal Adenocarcinoma: A Strobe-Compliant Observational Study. Medicine 2016 Mar 95 (10): e2936. Xiong Junjie, Altaf Kiran, Ke Nengwen, Wang Yichao, Tang Jie, Tan Chunlu, Li Ang, Zhang Hao, He Du, Liu Xub |
Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment. Leukemia & lymphoma 2017 12 58 (12): 2880-2894. Megías-Vericat Juan Eduardo, Montesinos Pau, Herrero María José, Moscardó Federico, Bosó Virginia, Martínez-Cuadrón David, Rojas Luis, Rodríguez-Veiga Rebeca, Boluda Blanca, Sendra Luis, Cervera José, Poveda José Luis, Sanz Miguel Ángel, Aliño Salvador |
Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer. PloS one 2019 3 14 (2): e0212097. Sissung Tristan M, Rajan Arun, Blumenthal Gideon M, Liewehr David J, Steinberg Seth M, Berman Arlene, Giaccone Giuseppe, Figg William |
Gene-Gene Interactions of Gemcitabine Metabolizing-Enzyme Genes hCNT3 and WEE1 for Preventing Severe Gemcitabine-Induced Hematological Toxicity. Journal of clinical pharmacology 2021 5 61 (10): 1376-1385. Li Juan, Chen Bing, Xi Wen-Qi, Yang Chen, Zhang Wei-X |
Pharmacogenetics of ABCB1, CDA, DCK, GSTT1, GSTM1 and outcomes in a cohort of pediatric acute myeloid leukemia patients from Colombia. Cancer reports (Hoboken, N.J.) 2022 11 e1744. Yunis Luz K, Linares-Ballesteros Adriana, Aponte Nelson, Barros Gisela, García Johnny, Niño Laura, Uribe Gloria, Quintero Edna, Yunis Juan |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: